Page 2 - Indian Healthcare System

Lymphatic filariasis not neglected disease for India, says Mandaviya

Lymphatic filariasis is not a neglected disease for India as may be the case in some other countries but is a priority for elimination in a time-bound manner, Union Health Minister Mansukh Mandaviya said Friday. Inaugurating the National Symposium on India's Roadmap to Eliminate Lymphatic Filariasis here, he reiterated India's commitment towards the target of eradicating the disease from the country by end of 2027. As part of its commitment to eliminate the disease by end of 2027, the health ministry has come up with a renewed five-pronged strategy as part of which multi-drug administration (MDA) will be held twice a year in synchronisation with National Deworming Day on February 10 and August 10, Mandaviya said. The other aspects of the strategy include early diagnosis and treatment; engagement of medical colleges for strengthening morbidity management and disability services; integrated vector control with multi-sectoral coordinated efforts; inter-sectoral convergence with allied

PM Modi-led govt has made Indian healthcare future-ready: MoS Education

The MoS shared that the mortality ratio--Maternal Mortality Ratio and Infant Mortality Ration has reduced under PM Modi

SC asks Centre, states to file response on uniform healthcare standard plea

The Supreme Court Friday directed the Centre and the states to file their responses on a plea seeking directions for a uniform standard of healthcare for citizens in line with the Constitution by adopting provisions of the Clinical Establishments Act, 2010. A bench of Justices B R Gavai and Vikram Nath granted four weeks to the Union of India and the state governments to file their replies. The top court was hearing a plea filed by Jan Swasthya Abhiyan, Patients' Rights Campaign and K M Gopakumar which had also sought directions for operationalising all the provisions of the Act, as well as Clinical Establishment Rules, 2012 in order to ensure affordable and quality healthcare. The plea had sought directions for notification and implementation of the conditions for registration of clinical establishments such as observance of minimum standards, display of rates for procedures and services, compliance with the standard treatment protocol, as provided in Sections 11 and 12 of the CEA

India to benefit from Israeli experience of managing health service: Expert

With India at the cusp of a digital healthcare revolution, the Israeli experience in managing its health services, especially in times of crisis, can be very helpful in the successful management

Covishield booster post Covaxin priming improves immune response 58x: CMC

So far, India has not allowed heterologous boosting of vaccines

Covid exposed a need for efficient healthcare delivery system: Amitabh Kant

Covid has exposed a need for efficient healthcare delivery system, said NITI Aayog CEO, adding that technology and research solution that provide data-based information quickly is the need of the hour

One village quelled Covid. The next was overrun. It's a bad sign for India

The uneven response to India's catastrophic second wave, coupled with widespread vaccine hesitancy, indicates that the coronavirus is here to stay.

India records 42,640 fresh coronavirus infections, lowest in 91 days

As many as 42,640 fresh Covid-19 infections were reported in the last 24 hours, the lowest daily spike after 91 days, the Union Health Ministry said on Tuesday

Alembic Pharmaceuticals gets USFDA nod for bipolar depression drug

Drug firm Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for Lurasidone Hydrochloride tablets, used to treat bipolar depression. The approved product is therapeutically equivalent to the reference listed drug product (RLD) Latuda tablets of Sunovion Pharmaceuticals Inc. The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Lurasidone Hydrochloride tablets in the strengths of 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg, Alembic Pharmaceuticals said in a regulatory filing. Quoting IQVIA data, Alembic Pharma said Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg have an estimated market size of USD 3.7 billion for the twelve months ending December 2020. Lurasidone Hydrochloride tablets are indicated for treatment of major depressive episodes associated with bipolar I disorder (bipolar depression). Alembic Pharma said it has settled the cas

'India will need 500,000 ICU beds, 350,000 medical staff in next few weeks'

At present, India has 90,000 ICU beds and almost all are already occupied - when the second wave of the pandemic hasn't even reached its peak yet, says noted surgeon Dr Devi Prasad Shetty

Second wave of Covid-19 to take a toll on Indian healthcare system: Fitch

India remains badly placed to tackle the rapid spread of Covid-19 despite several reforms and the unprecedented crisis has highlighted the need to increase investments in the healthcare sector

India rolls out coronavirus vaccination for all people above 45 years

The Covid-19 vaccination for all people aged 45 years and above commenced from Thursday, the Union Health Ministry said

India records highest one-day jump in Covid cases with 72,330 infections

India saw 72,330 new coronavirus infections being reported in a span of 24 hours, the highest single-day rise so far this year, taking the Covid-19 tally of cases to 12,221,665

Seven Covid vaccine candidates in clinical trials, says Harsh Vardhan

Union Health Minister Harsh Vardhan said that seven more Covid-19 vaccine candidates are in stages of clinical trials

India records 59,118 new infections as new coronavirus cases surge

India saw 59,118 new coronavirus infections in a day, the highest single day rise so far this year, taking the nationwide Covid-19 tally to 11,846,652

Maharashtra tops Covid-19 vaccination with 4 mn jabs, surpasses Rajasthan

Maharashtra has emerged as the leader in the Covid-19 vaccination drive as it has administered vaccine doses to 4,342,646 people, an official said on Thursday

National Commission for Allied and Healthcare Professions bill passed

The Parliament on Wednesday passed the National Commission for Allied and Healthcare Professions Bill, 2021

Stressed even in normal times, Indian health care held up in a crisis year

As anti-virus vaccines become the biggest productivity leap of the 21st century, India could possibly emerge as the destination of choice for products against a larger number of viral diseases

Intensify effort in Covid superspreader areas like malls: Delhi govt to DMs

Calling malls, cinema halls and religious places "superspreader" areas, the Delhi government has directed all district magistrates to greatly intensify enforcement of Covid-19 norms in such places

India records highest single-day spike with 47,262 fresh Covid-19 cases

India recorded 47,262 fresh coronavirus cases in a day, the highest single-day rise so far this year, taking the nationwide Covid-19 tally to 1,17,34,058, the Union health ministry said on Wednesday